vs

Side-by-side financial comparison of Quest Diagnostics (DGX) and Mobileye Global Inc. (MBLY). Click either name above to swap in a different company.

Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $1.9B, roughly 1.5× Mobileye Global Inc.). On growth, Mobileye Global Inc. posted the faster year-over-year revenue change (27.4% vs 9.2%). Over the past eight quarters, Mobileye Global Inc.'s revenue compounded faster (109.9% CAGR vs 9.9%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.

DGX vs MBLY — Head-to-Head

Bigger by revenue
DGX
DGX
1.5× larger
DGX
$2.9B
$1.9B
MBLY
Growing faster (revenue YoY)
MBLY
MBLY
+18.2% gap
MBLY
27.4%
9.2%
DGX
Faster 2-yr revenue CAGR
MBLY
MBLY
Annualised
MBLY
109.9%
9.9%
DGX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DGX
DGX
MBLY
MBLY
Revenue
$2.9B
$1.9B
Net Profit
$281.0M
Gross Margin
14.2%
Operating Margin
15.4%
Net Margin
9.7%
Revenue YoY
9.2%
27.4%
Net Profit YoY
12.0%
EPS (diluted)
$2.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGX
DGX
MBLY
MBLY
Q1 26
$2.9B
$1.9B
Q4 25
$2.8B
$446.0M
Q3 25
$2.8B
$504.0M
Q2 25
$2.8B
$506.0M
Q1 25
$2.7B
$438.0M
Q4 24
$2.6B
$490.0M
Q3 24
$2.5B
$486.0M
Q2 24
$2.4B
$439.0M
Net Profit
DGX
DGX
MBLY
MBLY
Q1 26
$281.0M
Q4 25
$245.0M
$-127.0M
Q3 25
$245.0M
$-96.0M
Q2 25
$282.0M
$-67.0M
Q1 25
$220.0M
$-102.0M
Q4 24
$222.0M
$-71.0M
Q3 24
$226.0M
$-2.7B
Q2 24
$229.0M
$-86.0M
Gross Margin
DGX
DGX
MBLY
MBLY
Q1 26
14.2%
Q4 25
32.4%
45.3%
Q3 25
33.7%
48.2%
Q2 25
34.2%
49.8%
Q1 25
32.5%
47.3%
Q4 24
32.7%
49.2%
Q3 24
32.6%
48.8%
Q2 24
33.5%
47.6%
Operating Margin
DGX
DGX
MBLY
MBLY
Q1 26
15.4%
Q4 25
13.8%
-31.4%
Q3 25
13.7%
-21.6%
Q2 25
15.9%
-14.6%
Q1 25
13.0%
-26.7%
Q4 24
13.8%
-17.6%
Q3 24
13.3%
-577.6%
Q2 24
14.8%
-21.4%
Net Margin
DGX
DGX
MBLY
MBLY
Q1 26
9.7%
Q4 25
8.7%
-28.5%
Q3 25
8.7%
-19.0%
Q2 25
10.2%
-13.2%
Q1 25
8.3%
-23.3%
Q4 24
8.5%
-14.5%
Q3 24
9.1%
-558.6%
Q2 24
9.6%
-19.6%
EPS (diluted)
DGX
DGX
MBLY
MBLY
Q1 26
$2.24
Q4 25
$2.18
$-0.15
Q3 25
$2.16
$-0.12
Q2 25
$2.47
$-0.08
Q1 25
$1.94
$-0.13
Q4 24
$1.95
$-0.09
Q3 24
$1.99
$-3.35
Q2 24
$2.03
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGX
DGX
MBLY
MBLY
Cash + ST InvestmentsLiquidity on hand
$393.0M
$1.2B
Total DebtLower is stronger
$5.7B
Stockholders' EquityBook value
$7.7B
$8.2B
Total Assets
$16.7B
$8.7B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGX
DGX
MBLY
MBLY
Q1 26
$393.0M
$1.2B
Q4 25
$420.0M
$1.8B
Q3 25
$432.0M
$1.7B
Q2 25
$319.0M
$1.7B
Q1 25
$188.0M
$1.5B
Q4 24
$549.0M
$1.4B
Q3 24
$764.0M
$1.3B
Q2 24
$271.0M
$1.2B
Total Debt
DGX
DGX
MBLY
MBLY
Q1 26
$5.7B
Q4 25
$5.2B
Q3 25
$5.2B
Q2 25
$5.2B
Q1 25
$5.9B
Q4 24
$5.6B
Q3 24
$5.6B
Q2 24
$3.8B
Stockholders' Equity
DGX
DGX
MBLY
MBLY
Q1 26
$7.7B
$8.2B
Q4 25
$7.2B
$11.9B
Q3 25
$7.3B
$11.9B
Q2 25
$7.2B
$12.1B
Q1 25
$6.9B
$12.0B
Q4 24
$6.8B
$12.1B
Q3 24
$6.8B
$12.1B
Q2 24
$6.6B
$14.7B
Total Assets
DGX
DGX
MBLY
MBLY
Q1 26
$16.7B
$8.7B
Q4 25
$16.2B
$12.5B
Q3 25
$16.2B
$12.5B
Q2 25
$16.0B
$12.6B
Q1 25
$15.8B
$12.5B
Q4 24
$16.2B
$12.6B
Q3 24
$16.1B
$12.6B
Q2 24
$13.9B
$15.3B
Debt / Equity
DGX
DGX
MBLY
MBLY
Q1 26
0.74×
Q4 25
0.72×
Q3 25
0.71×
Q2 25
0.72×
Q1 25
0.85×
Q4 24
0.83×
Q3 24
0.83×
Q2 24
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGX
DGX
MBLY
MBLY
Operating Cash FlowLast quarter
$278.0M
$75.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGX
DGX
MBLY
MBLY
Q1 26
$278.0M
$75.0M
Q4 25
$465.0M
$113.0M
Q3 25
$563.0M
$167.0M
Q2 25
$544.0M
$213.0M
Q1 25
$314.0M
$109.0M
Q4 24
$464.0M
$204.0M
Q3 24
$356.0M
$126.0M
Q2 24
$360.0M
$30.0M
Free Cash Flow
DGX
DGX
MBLY
MBLY
Q1 26
Q4 25
$307.0M
$86.0M
Q3 25
$419.0M
$143.0M
Q2 25
$436.0M
$199.0M
Q1 25
$197.0M
$95.0M
Q4 24
$341.0M
$191.0M
Q3 24
$250.0M
$104.0M
Q2 24
$268.0M
$6.0M
FCF Margin
DGX
DGX
MBLY
MBLY
Q1 26
Q4 25
10.9%
19.3%
Q3 25
14.9%
28.4%
Q2 25
15.8%
39.3%
Q1 25
7.4%
21.7%
Q4 24
13.0%
39.0%
Q3 24
10.0%
21.4%
Q2 24
11.2%
1.4%
Capex Intensity
DGX
DGX
MBLY
MBLY
Q1 26
3.9%
Q4 25
5.6%
6.1%
Q3 25
5.1%
4.8%
Q2 25
3.9%
2.8%
Q1 25
4.4%
3.2%
Q4 24
4.7%
2.7%
Q3 24
4.3%
4.5%
Q2 24
3.8%
5.5%
Cash Conversion
DGX
DGX
MBLY
MBLY
Q1 26
0.99×
Q4 25
1.90×
Q3 25
2.30×
Q2 25
1.93×
Q1 25
1.43×
Q4 24
2.09×
Q3 24
1.58×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons